Oversubscribed Series B financing co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from ...
Sapu Nano and Oncotelic Therapeutics (OTCQB:OTLC) today announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global ...
Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to improving the lives of people with chronic lung diseases including COPD and asthma, today announced two key additions to the ...
More flexibility in early-phase development for cell therapies is needed, a panel of US Food and Drug Administration (FDA) ...
The survey was conducted by the Pistoia Alliance at the Clinical Trials Technology Congress (CTTC) in London.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH) (the “Company”), a leading global life sciences company, today announced that its Board of Directors has authorized the Company to pursue a ...
ACT Brief: Clinical Development Orchestration, Career Insights in Trials, and FDA Communication Gaps
In today's ACT Brief, we examine how program-level orchestration is becoming critical to R&D success, reflections on ...
In a recent video interview with Applied Clinical Trials, Sam Hinsley, statistics manager at Phastar, discussed the critical ...
Discusses Clinical Data and Updated Development Strategy for Darlifarnib June 3, 2026 3:15 PM EDTCompany ParticipantsTroy ...
In countries with the best cancer outcomes, approximately 60% of patients receive radiotherapy as part of their treatment, which is one of the most cost-effective cancer treatments. Notably, around 40 ...
InvestorsHub on MSN
CEPI awards funding to advance Ebola Bundibugyo vaccine development
Global health organisation CEPI has committed approximately $60 million to Moderna (NASDAQ:MRNA) and two additional research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results